SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001157523-10-003803
Filing Date
2010-06-24
Accepted
2010-06-24 16:30:32
Documents
9

Document Format Files

Seq Description Document Type Size
1 AVANYX THERAPEUTICS, INC. S-1/A a6324059.htm S-1/A 969490
3 EXHIBIT 3.1 a6324059ex3-1.htm EX-3.1 51200
4 EXHIBIT 10.1 a6324059ex10-1.htm EX-10.1 24055
5 EXHIBIT 10.2 a6324059ex10-2.htm EX-10.2 344543
6 EXHIBIT 10.3 a6324059ex10-3.htm EX-10.3 18763
7 EXHIBIT 23.1 a6324059ex23-1.htm EX-23.1 4482
8 LOGO logo.jpg GRAPHIC 17349
9 GRAPHIC footer.jpg GRAPHIC 26144
10 filename10.htm CORRESP 94503
  Complete submission text file 0001157523-10-003803.txt   1568913
Mailing Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101
Business Address 33 SOUTH COMMERCIAL STREET MANCHESTER NH 03101 978-886-0421
AVANYX Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-164785 | Film No.: 10915274
SIC: 2834 Pharmaceutical Preparations